Influenza Vaccine

3 Drugs classified under this drug class

Influenza Vaccine. A/Hong Kong/4801/2014 (H3N2) - like strain 15 mcg / 0.5 ml, A/Michigan/45/2015 (H1N1)pdm09 - like strain 15 mcg / 0.5 ml, B/Brisbane/60/2008 - like strain 15 mcg / 0.5 ml, B/Phuket/3073/2013 - like strain 15 mcg / 0.5 ml.
PRE-FILL. SYR.: 1, 10×0.5ml. Child. from 36 mnths. onwards: 0.5 ml.
For child. aged < 9 yrs., who have not
previous. been vaccine. against
influenza, a 2ND dose should be given
after an interv. of at least 4 wks.
Child. < than 3 yrs. : the safety and
efficacy of this vaccine in child. less
than 3 yrs. have not been established.
See lit.
Active immunis. of adults & child. from 3
yrs. of age for the prevent. of influenza
dis. caused by the two influenza A virus
subtypes and the two influenza B virus
types contain. in the vaccine.
C/I: Hypersens. to the active substan. or
to any compon. that may be present as
traces such as eggs (ovalbumin, chicken
protein. ), formaldehyde, gentamicin
sulphate and sodium deoxycholate.
Immunis. should be postponed in pts.
with febrile illness or acute infec.

Influenza Vaccine. A/Hong Kong/4801/2014 (H3N2) - like strain 15 mcg/dose, A/Michigan/45/2015 (H1N1)pdm09 - like strain 15 mcg/dose, B/Brisbane/60/2008 - like strain 15 mcg/dose.
PFS: 1 x 0.5 ml. See lit.
Influenza vaccine.

Influenza Vaccine. A/Michigan/45/2015 (H1N1)pdm09 - like strain 15 mcg / 0.5 ml, B/Phuket/3073/2013 - like strain 15 mcg / 0.5 ml, B/Colorado/06/2017 - like strain 15 mcg / 0.5 ml, A/Singapore/INFIMH-16-0019/2016 (H3N2) - like strain 15 mcg / 0.5 ml.
PRE-FILL. SYR.( suspens. for inj.): 1×0.5ml.
Adults: one dose of 0.5 ml.
Paed. popul.: Child. from 6 mnths.-17 yrs. of age: one dose of 0.5 ml.
For child. less than 9 yrs. of age who have not prev. been vaccine., a 2^nd dose of 0.5 ml should be given after an interv. of at least 4 wks.
Child. less than 6 mnths. of age: the safety and efficacy of this vaccine have not been established. No data are available.
Indicated for active immunis. of adult. & child. from 6 mnths. of age and older for the prevent. of influenza dis. caused by the two influenza A virus subtypes and the two influenza B virus types contain. in the vaccine.
The use of this formulation should be based on official recommendat.
C/I: Hypersens. to the active substances, or to any component that may be present as traces such as eggs (ovalbumin, chicken proteins), neomycin, formaldehyde and octoxinol-9. Vaccination should be postponed in case of moder.- sev. febrile dis. or acute dis.